Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study

Publication date: Available online 13 August 2020Source: Autoimmunity ReviewsAuthor(s): Philippe Mertz, Jean-François Kleinmann, Marc Lambert, Xavier Puéchal, Anthony Bonnin, Carine Boulon, Elisabeth Diot, Eric Hachulla, Naoual Harid, Jean-Robert Harle, Gil Helder, Jean-Emmanuel Kahn, Isabelle Kone-Paut, Christian Lavigne, Nadine Magy-Bertrand, Helene Maillard, Thierry Martin, François Maurier, Vincent Poindron, Nicolas Schleinitz
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research